Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.
10th Annual Biotech in Europe Investor Forum
September 29-30, 2010, Zurich, Switzerland
Click here for further information
GLSV Annual Investors Meeting
June 17, 2010, Munich, Germany
BioEquity Europe 2010
May 19-20, 2010, Zurich, Switzerland
Click here for further information
3rd Annual European Life Science CEO Forum
February 11-12, 2010, Zurich, Switzerland
Click here for further information